Schistosomiasis and Pulmonary Hypertension
Carregando...
Citações na Scopus
Tipo de produção
bookPart
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Autores
MORINAGA, Luciana Kato
Citação
Schistosomiasis and Pulmonary Hypertension. In: Humbert, M; Souza, R; Simonneau, G (eds). PULMONARY VASCULAR DISORDERS, v.41. BASEL: KARGER, 2012. p.143-148. (Progress in Respiratory Research)
Resumo
Schistosomiasis is the third leading parasitic disease in the world. It is present in 74 countries, infecting 200 million people. Each year 280,000 patients die because of the disease. One of its most severe complications is pulmonary arterial hypertension (PAH). Previous studies have shown that 5% of patients with hepatosplenic schistosomiasis develop PAH. It is believed today that the most prevalent cause worldwide of PAH is schistosomiasis. Specifics about schistosomiasis-associated PAH including epidemiological data, mechanisms of the disease, clinical and hemodynamic features, and modalities of treatment will be reviewed in this chapter. Copyright (C) 2012 S. Karger AG, Basel
Palavras-chave
Referências
- AZMY S., 1932, Journal of the Egyptian Medical Association, V15, P87
- Bilharz T, 1853, Z WISS ZOOL, V4, P454
- BOUREE P, 1990, B SOC PATHOL EXOT, V83, P66
- Chaves E, 1965, Hospital (Rio J), V68, P635
- CHAVES E, 1966, DIS CHEST, V50, P72
- Crosby A, 2010, AM J RESP CRIT CARE, V181, P279, DOI 10.1164/rccm.200903-0355OC
- Fernandes CJCD, 2010, J AM COLL CARDIOL, V56, P715, DOI 10.1016/j.jacc.2010.03.065
- Figueiredo C, 2004, AM J RESP CRIT CARE, V169, pA174
- Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009
- HADENGUE A, 1991, GASTROENTEROLOGY, V100, P520
- HATZ C, 1992, ACTA TROP, V51, P15, DOI 10.1016/0001-706X(92)90017-R
- Igreja RP, 2007, ANN TROP MED PARASIT, V101, P575, DOI 10.1179/136485907X229086
- Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221
- Lapa Monica Silveira, 2006, Rev Assoc Med Bras, V52, P139, DOI 10.1590/S0104-42302006000300012
- Le Pavec J, 2008, AM J RESP CRIT CARE, V178, P637, DOI 10.1164/rccm.200804-613OC
- Loureiro R, 2004, ORAL SILDENAFIL IMPR
- Meira J, 1991, CLIN DOENCAS TROPICA, P401
- Pereira GA, 2002, T ROY SOC TROP MED H, V96, P427, DOI 10.1016/S0035-9203(02)90381-0
- Pozzan G, 2008, AM J RESP CRIT CARE, V177, pA443
- Prata A, 1991, DOENCAS INFECCIOSAS, P838
- Rich S, 1998, WORLD S PRIM PULM HY
- Richter J, 2000, ACTA TROP, V77, P111, DOI 10.1016/S0001-706X(00)00125-X
- Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396
- Salanitri John, 2002, Australas Radiol, V46, P435, DOI 10.1046/j.1440-1673.2002.01100.x
- Shaw AFB, 1938, J PATHOL BACTERIOL, V46, P401, DOI 10.1002/path.1700460302
- Simmonneau G, 2004, J AM COLL CARDIOL, V43, p5S
- [Anonymous], 2009, J AM COLL CARDIOL, V54, P43
- Vennervald BJ, 2004, CURR OPIN INFECT DIS, V17, P439, DOI 10.1097/00001432-200410000-00009